$224.32
-8.63-3.70%
At close: -
$224.00
-0.32-0.14%
After Hours: 4:34 PM EDT
Comments
Loading...
Latest Alnylam Pharmaceuticals Stock News | NASDAQ:ALNY | Benzinga
Get the latest news on Alnylam Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Alnylam Pharmaceuticals performance
Categories: All
Friday, April 04, 2025
Wednesday, April 02, 2025
Monday, March 31, 2025
- 27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know
- Scotiabank Maintains Sector Outperform on Aln...
- If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
- Redburn Atlantic Initiates Coverage On Alnyla...
- FDA Approves Sanofi's Hemophilia Drug
- Stifel Maintains Buy on Alnylam Pharmaceutica...
- Reported Saturday, Alnylam Presents HELIOS-B ...
Friday, March 28, 2025
Monday, March 24, 2025
Sunday, March 23, 2025
Friday, March 21, 2025
- Citigroup Maintains Buy on Alnylam Pharmaceut...
- Check Out What Whales Are Doing With ALNY
- Canaccord Genuity Maintains Buy on Alnylam Ph...
- RBC Capital Maintains Outperform on Alnylam P...
- Scotiabank Maintains Sector Outperform on Aln...
- Alnylam's Amvuttra Secures FDA Approval For Expanded Use For Rare Heart Disease, Stock Jumps
- Wells Fargo Maintains Equal-Weight on Alnylam...
- Alnylam Pharmaceuticals shares are trading hi...
- B of A Securities Maintains Buy on Alnylam Ph...
- Chardan Capital Maintains Buy on Alnylam Phar...
- Needham Reiterates Buy on Alnylam Pharmaceuti...